Psychedelics Today

Download In this episode, hosts Kyle and Joe interview Balázs Szigeti, PhD and David Erritzoe, PhD to discuss the self-blinded microdosing study in collaboration with the Imperial College London. In this episode, they explore the self-blinding study and it’s pros and limitations, with the aim to collect data on microdosing and its possible benefits. 3 Key Points: Microdosing (LSD) has the least amount of research so far among research on drugs like Psilocybin, MDMA and Ketamine. This microdosing study includes a procedure on how self experimenters can implement placebo control. This will help determine whether microdosers feel benefits due to the placebo effect or because of the pharmacological action of the microdose. Just because microdosing may have a placebo effect (the way a user feels while taking it) it may actually have benefits that one cannot necessarily ‘feel’ (users may become more creative, have better problem solving skills, etc). Support the show Patreon Leave us a review on iTunes Share